A Phase I, Randomised, Open, Single-Centre, Three-Period Crossover Study to Evaluate the Effect of AZD1305 on the Pharmacokinetics of Digoxin After Repeated Oral Administration of AZD1305 and Digoxin to Young Healthy Male Volunteers

Trial Profile

A Phase I, Randomised, Open, Single-Centre, Three-Period Crossover Study to Evaluate the Effect of AZD1305 on the Pharmacokinetics of Digoxin After Repeated Oral Administration of AZD1305 and Digoxin to Young Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Dec 2010

At a glance

  • Drugs AZD 1305 (Primary) ; Digoxin
  • Indications Arrhythmias
  • Focus Pharmacokinetics
  • Sponsors AstraZeneca
  • Most Recent Events

    • 13 Jan 2009 Status changed from not yet recruiting to completed, according to the clinicaltrials.gov record.
    • 30 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top